chemist warehouse semaglutide Ozempic, GLP1 drugs drive major growth for Replying to @Michelle May -

Forty-six states and Washington, D.C., run at least one, with creative ideas focused on meeting social needs, services for people re-entering communities from the criminal justice system, and coverage expansions

GLP-1 receptor agonists decrease toxic alcohol metabolites The researchers found that GLP-1 receptor agonists reduce levels of a key liver enzyme called Cyp2e1, which converts alcohol into acetaldehydea toxic compound responsible for much of alcohols damaging effects on the liver

You don't need a diabetes diagnosis to benefit from GLP-1 medications

There are two distinct pieces of news here

These studies came from Canada and Australia, respectively